A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients

Drooling Clinical Trial

Official title:
A Multi-Center, Randomized, Double-blind, Placebo-Controlled,Sequential Dose Escalation, Safety, Tolerability, and Preliminary Efficacy Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients

Status Completed

Clinical Trial Summary

To determine safety, tolerability and preliminary efficacy of intraglandular injections of MYOBLOC for the treatment of sialorrhea in Parkinsons' Disease patients

Clinical Trial Description

This is a multi-center, outpatient, double-blind, placebo-controlled, single treatment, sequential dose escalation study designed to evaluate the safety, tolerability and preliminary efficacy of single doses of MYOBLOC versus placebo for the treatment of sialorrhea in Parkinson's disease patients, lasting approximately 20 weeks. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00515437
Study type	Interventional
Source	US WorldMeds LLC
Contact
Status	Completed
Phase	Phase 2
Start date	July 2007
Completion date	September 2008

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT00173745` - Treatment of Drooling With Type A Botulinum Toxin in Children With Cerebral Palsy	N/A
Completed	`NCT03986333` - Validation of the French Version of the Drooling Impact Scale in a Pediatric Cerebral Palsy Population
Not yet recruiting	`NCT01249885` - Implications of Pacifier Use in Israeli Children	N/A
Recruiting	`NCT04266626` - Effectiveness of Kinesiotaping and Manipulation Therapies in Drooling Management Among Children With Oral Dysphagia	N/A
Completed	`NCT05524831` - Kinesio Taping Versus Oromotor Training on Drooling in Children With Spastic Cerebral Palsy	N/A
Not yet recruiting	`NCT06355141` - Oral Structural and Functional Problems in Children With Autism